GOLDMAN SACHS GROUP INC

Position in PRAX — Praxis Precision Medicines, Inc.

CIK 886982 NEW YORK, NY

Position in PRAX

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$228,991,385

+$17,903,315 QoQ

Shares Held

710,734

-0.8% QoQ

Ownership

2.55%

of shares outstanding

% of Portfolio

0.04%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2024

9 quarters on record

Voting authority Sole 99.47434623923999.ToString("F0")% Shared 0.13422743248528984.ToString("F0")% None 0.39142632827471313.ToString("F0")%

Healthcare · as of Mar 31, 2026

GOLDMAN SACHS GROUP INC holds $10,293,152,367 across 364 Biotechnology names. PRAX ranks #5 (2.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	2,417,875	$1,079,677,898
2	REGN	Regeneron Pharmaceuticals, Inc.	1,300,558	$1,004,863,129
3	MRNA	Moderna, Inc.	6,603,697	$335,467,805
4	ROIV	Roivant Sciences Ltd.	11,111,591	$307,791,069
5	PRAX	Praxis Precision Medicines, Inc. This page	710,734	$228,991,385
6	INCY	Incyte Corp	2,351,221	$221,296,919
7	RVMD	Revolution Medicines, Inc.	2,185,500	$212,539,874
8	RYTM	Rhythm Pharmaceuticals, Inc.	1,965,432	$170,933,620

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$228,991,385	710,734	-0.8%	Shares	Defined	2026-05-15
2025-12-31	$211,088,070	716,184	+20.8%	Shares	Defined	2026-03-25
2025-09-30	$31,430,113	593,021	+162.4%	Shares	Defined	2025-11-14
2025-06-30	$9,502,963	225,992	+27.5%	Shares	Defined	2025-08-14
2025-03-31	$6,712,986	177,264	-36.6%	Shares	Defined	2025-06-27
2024-12-31	$21,502,238	279,395	-0.1%	Shares	Defined	2025-02-11
2024-09-30	$16,089,333	279,620	+113.5%	Shares	Defined	2024-11-14
2024-06-30	$5,418,034	130,997	+32.8%	Shares	Defined	2024-08-13
2024-03-31	$6,018,707	98,635	—	Shares	Defined	2024-05-15
No filing history on record for this holder in this stock.